Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fungal cytochrome P450 14-α-demethylase is an essential enzyme in ergosterol biosynthesis, serving as the principal target for azole antifungal drugs. Its inhibition compromises fungal membrane integrity and viability. Resistance arises through gene mutations and overexpression. Cell membrane phospholipids, while critical for fungal structure and function, are a molecular class—not a direct drug target.
Inhibition of ergosterol biosynthesis by binding active site heme, disruption of membrane function
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal cytochrome P450 14-α-demethylase (CYP51 (ERG11)).